Montana Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Angiographic Control vs Ischemia-Driven Management of Patients Treated With PCI on Left Main With Drug-Eluting Stents
  In the PULSE trial, CCTA following PCI for unprotected left main disease failed to reduce the composite primary endpoint of all-cause death, spontaneous MI, unstable angina, or definite or probable stent thrombosis.
• Olezarsen in Patients With Hypertriglyceridemia at High Cardiovascular Risk
  The Essence-TIMI 73b trial demonstrated that olezarsen, compared with placebo, significantly reduced triglyceride levels in patients with moderate hypertriglyceridemia and elevated cardiovascular risk.
• ACC CardiaCast: Innovation in Action: AI-Enabled ECG: From Concept to Clinical Care
  In this episode with Drs. Francisco Lopez-Jimenez and Paul Friedman, ACC Chief Innovation Officer Dr. Ami Bhatt explores the rapid rise of artificial intelligence (AI) tools in cardiovascular care, highlighting why screening tools such as the electrocardiogram (ECG) are particularly well-suited for innovation.
• ACC Releases Expert Consensus Decision Pathway on TR Evaluation and Management
  The ACC has released a new Expert Consensus Decision Pathway (ECDP) addressing "10 issues for the clinician in tricuspid regurgitation (TR) evaluation and management."
• Top Posters at ACC Latin America 2025 Explore Myocardial Contraction Fraction, Vericiguat in HFrEF, Long COVID
  As hundreds of participants gathered to share and learn about the latest science from the Latin America region, the top three posters from ACC Latin America 2025 earned a spot to present at ACC.26 in New Orleans, LA.